Blood ACE Activity Is Significantly Lowered in Psoriasis Compared to Atopic Dermatitis: A Small Pilot Study in Young Males
Authors:
Open Access
- 20 July 2026
- journal article
- research article
- Published by Springer Nature in Current Medical Science
- Vol. 46 (4) , 1115-1120
Abstract
Purpose: Emerging evidence suggests the involvement of the renin-angiotensin system (RAS) in the pathogenesis and progression of autoimmune dermatological diseases. In a small exploratory study, we investigated angiotensin-converting enzyme (ACE) activity in blood obtained from male probands with psoriasis vulgaris (n = 4) and atopic dermatitis (AD, n = 5). Methods: The degradation capacity of dabsylated synthetic bradykinin (DBK) with and without inhibition was determined using a thin-layer chromatography (TLC)-based neuropeptide reporter assay. Results: We observed a significantly reduced capacity for cleavage of DBK in psoriasis patients compared with that in AD patients and controls. In patient samples, the variation in the measured values was generally greater than that in healthy controls. We could not confirm the increased ACE activity in the circulation in psoriasis patients reported by others, likely because of different study designs and detection methods. We did not include samples of female patients and focused on younger men to avoid hormonal effects and minimize age-related factors. Conclusion: This preliminary study of the hypothesis-generating nature lacks power, but it certainly adds a question to the current view of the role of ACE in psoriasis. Treatments targeting specific components of the RAS could ameliorate inflammatory responses; thus, research in this area is becoming increasingly important.Keywords
Funding Information
- Westfälische Wilhelms-Universität Münster
This publication has 22 references indexed in Scilit:
- How to Prevent Atopic Dermatitis (Eczema) in 2024: Theory and EvidenceThe Journal of Allergy and Clinical Immunology: In Practice, 2024
- The Immunology of Psoriasis—Current Concepts in PathogenesisClinical Reviews in Allergy & Immunology, 2024
- Angiotensin converting enzyme and angiotensin converting enzyme inhibitors in dermatology: a narrative reviewExpert Review of Clinical Pharmacology, 2022
- Angiotensin-converting enzyme and subclinical atherosclerosis in psoriasis: Is there any association? A case-control studyJournal of the American Academy of Dermatology, 2020
- Neuropeptide reporter assay for serum, capillary blood and blood cardsMethodsX, 2020
- The serum protease network—one key to understand complex regional pain syndrome pathophysiologyPain, 2019
- Serum biomarker profiles suggest that atopic dermatitis is a systemic diseaseJournal of Allergy and Clinical Immunology, 2018
- A vote for robustness: Monitoring serum enzyme activity by thin-layer chromatography of dabsylated bradykinin productsJournal of Pharmaceutical and Biomedical Analysis, 2017
- Angiotensin-converting Enzyme Inhibitors as Inducers of Adverse Cutaneous ReactionsActa Dermato-Venereologica, 2001
- Serum angiotensin-converting enzyme in sarcoidosis and psoriasisArchives of Dermatological Research, 1984